LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Leucocyte VCS Parameters Evaluated for Pathogenic Infections

By LabMedica International staff writers
Posted on 16 Feb 2021
Image: The DxH 800 hematology analyzer, can utilize accurate data about individual cell size, shape and structure to provide high-quality first-pass results with VCS technology (Photo courtesy of Beckman Coulter Inc).
Image: The DxH 800 hematology analyzer, can utilize accurate data about individual cell size, shape and structure to provide high-quality first-pass results with VCS technology (Photo courtesy of Beckman Coulter Inc).
Malaria and dengue are highly endemic in most parts of India. Mangalore, a city in coastal Karnataka, India, has high prevalence of both these vector‐borne infections with extensive range of clinical presentations. The outbreak of these infections is common during and after the rainy season.

Clinical symptoms of these infections intersect each other and those seen in leptospirosis, typhoid fever and rickettsial infections. The latter three, though not as common as malaria and dengue fever, pose diagnostic difficulties in their early phases. The clinical presentation can vary from a mild febrile illness to lethal complications such as disseminated intravascular coagulation.

Medical Laboratory Scientists at the Kasturba Medical College (Manipal, India) compared automated parameters by VCS technology that can predict and aid in rapid and reliable prediction of specific infections such as malaria, dengue, leptospirosis, typhoid and rickettsial infections. This technology quantifies volume of the cells by voltage impedance (V); nuclear‐cytoplasmic ratio by radiofrequency conductivity (C); and internal cellular features such as cytoplasmic granularity and nuclear complexity by laser light scatter (S) and hence known as VCS technology. A total of 324 patients fulfilled the inclusion criteria of infection group and equal number of controls were included in the study.

The scientists used the Coulter DXH800 hematology analyzer (Beckman Coulter Inc., Miami, FL, USA). Serologically positive cases of dengue, leptospirosis, typhoid and rickettsia; and malaria cases diagnosed by florescence microscopy‐ quantitative buffy coat (QBC) method and were confirmed by peripheral smear examination. The dengue cases were taken as positive based on positivity using either dengue NS1 test (immunochromatography card) or dengue IgM Panbio ELISA, and the leptospirosis cases were considered positive based on IgM Panbio ELISA test (Panbio Inc. Brisbane, Australia).

The team reported that a total of 324 cases comprising of malaria (50%), dengue (30.9%), leptospirosis (13.9%), typhoid (4.0%) and rickettsial infections (1.2%) were included. There was statistically significant differences in the mean values of complete blood count parameters—hemoglobin, total leucocyte count, red blood cell count, hematocrits, red cell distribution width, differential leucocyte count, platelet count and plateletcrit between cases and controls and also between specific infections. The mean volumes of neutrophil, monocyte and lymphocyte were considerably increased in malaria and dengue fever compared to leptospirosis, typhoid and rickettsial infections. VCS parameters were the least altered in typhoid fever, except for a strikingly high conductivity and scatter of eosinophils.

The authors concluded that there was significant difference in the volume, conductivity and scatter of neutrophils, monocytes and lymphocytes between the five groups and the values are found to be greatest in malaria. Mean neutrophil volume (MNV), mean lymphocyte volume (MLV) and mean monocyte volume (MMV) were increased significantly in malaria and dengue fever compared to leptospirosis, typhoid and rickettsial infections. Dengue cases showed significantly higher values in most of the leucocyte light scatter data. The study was published on February 4, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
Kasturba Medical College
Beckman Coulter Inc
Panbio Inc


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Gel Cards
DG Gel Cards

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more